对托科利斯使用和早产管理的洞察:瑞士的横截面调查
Martin Kiebler1,2, Ana Paula Simões-Wüst1,2, Nicole Ochsenbein-Kölble1,2
1Department of Obstetrics, University Hospital Zurich, Zurich, Switzerland.
Swiss medical weekly
|December 9, 2025
概括
大多数瑞士产科医生遵循早产指南,但有些人仍然比推的时间更长的时间使用托科利斯. 需要加强教育,以使临床实践与基于证据的托科里斯建议保持一致.
科学领域:
- 产科和妇科 产科和妇科
- 新生儿医学 新生儿医学
- 临床实践指南 临床实践指南
背景情况:
- 过早分娩是新生儿发病率和死亡率的主要原因.
- 催产剂用于抑制早产儿收缩,并允许产前皮质类固醇用于肺成熟.
- 指导方针建议将托科利斯限制在48小时内,并且不能超过34周的妊娠期.
研究的目的:
- 评估瑞士目前的托科里斯和产前皮质类固醇治疗的现实做法.
- 评估这些做法是否与早产管理的国际和国家指导方针保持一致.
主要方法:
- 从2024年2月15日到5月30日进行了一项全国横截面调查.
- 一个匿名的在线问卷被分发给瑞士的产科医生.
- 该调查评估了毒解的持续时间和时间,数据按医生组分层.
主要成果:
- 54%的参与者仍在练习维护托科利西斯.
- 80%的人遵守了关于34周妊娠限量的指导方针,而20%的人超越了它.
- 在特殊情况下,尽管在指示和禁忌的优先级上有相似之处,但在托科里斯使用的变化被注意到.
结论:
- 大多数瑞士产科医生符合早产指导方针,但在托科里斯持续时间和时间方面存在差异.
- 显著的少数人继续在怀孕34周以后发生结肠裂.
- 加强教育和实施战略是必要的,以改善对基于证据的实践的坚持.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
382
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
382
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Drug Dosing: Infants and Children
234
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
234
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
929
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
929


